IBOV 169,277.30 ▼ 0.32% IPC MEX 70,388.96 ▼ 1.15% MERVAL 2,848,945 — — USD/BRL5.82▲ 0.76% USD/MXN18.69▲ 1.48% USD/CLP1,005▲ 1.23% USD/COP3,339▲ 0.65% USD/PEN3.41▲ 0.05% USD/ARS1,552▼ 0.02% USD/UYU40.61▲ 3.30% USD/PYG6,212▲ 3.32% USD/BOB11.64▲ 3.07% USD/DOP60.20▼ 0.17% USD/CRC441.73▲ 2.50% USD/GTQ7.64▲ 3.28% USD/HNL26.89▼ 0.10% USD/NIO36.62▲ 0.34% USD/VES913.46▼ 0.22% USD/PAB1.00— 0.00% USD/BZD2.00— 0.00% USD/JMD157.39▲ 2.57% USD/TTD6.70▲ 1.98% EUR/BRL6.38▲ 0.44% BRENT 89.21 ▼ 4.22% WTI 82.94 ▼ 3.57% IRON ORE 161.91 — — COPPER 5.66 ▼ 5.29% GOLD 3,758 ▼ 2.75% SILVER 44.96 ▼ 4.93% SOY 1,218 ▼ 0.61% CORN 441.25 ▼ 1.23% WHEAT 593.75 ▼ 0.25% COFFEE 273.55 ▼ 4.55% SUGAR 18.17 — 0.00% ORANGE JUICE 129.40 ▼ 4.15% COTTON 80.95 ▲ 4.69% COCOA 5,002 ▼ 0.56% BEEF 218.75 ▼ 0.01% CATTLE 336.30 ▲ 0.22% LITHIUM 55.54 ▼ 1.57% PETR4 42.97 ▼ 2.30% VALE3 59.00 ▼ 2.22% ITUB4 40.40 ▼ 1.20% BBDC4 14.26 ▼ 1.04% ABEV3 15.97 ▲ 0.25% BBAS3 14.27 ▼ 2.39% B3SA3 14.12 ▼ 3.62% WEGE3 51.28 ▲ 0.25% PRIO3 62.06 ▼ 2.97% SUZB3 55.18 ▼ 0.38% RENT3 29.78 ▲ 0.40% AZZA3 16.12 ▲ 3.07% CSAN3 3.22 ▼ 0.92% RAIZ4 18.49 ▼ 3.24% PCAR3 3.03 ▲ 4.84% GMAT3 4.15 ▼ 0.72% PSSA3 44.87 ▼ 2.29% CVCB3 0.78 — 0.00% POSI3 3.23 ▲ 3.19% SLCE3 17.89 ▼ 0.94% NATU3 4.89 ▲ 2.95% BRKM5 2.61 ▼ 5.09% RANI3 8.08 ▼ 1.70% CSNA3 3.78 ▲ 0.27% IBOV 169,277.30 ▼ 0.32% IPC MEX 70,388.96 ▼ 1.15% MERVAL 2,848,945 — — USD/BRL 5.82 ▲ 0.69% USD/MXN 18.69 ▲ 1.45% USD/CLP 1,005 ▲ 1.24% USD/COP 3,327 ▲ 0.30% USD/PEN 3.41 ▲ 0.05% USD/ARS 1,558 ▲ 0.34% USD/UYU 40.61 ▲ 3.30% USD/PYG 6,212 ▲ 3.32% USD/BOB 11.64 ▲ 3.07% USD/DOP 60.14 ▼ 0.27% USD/CRC 441.73 ▲ 2.50% USD/GTQ 7.64 ▲ 3.28% USD/HNL 26.89 ▼ 0.10% USD/NIO 36.62 ▲ 0.34% USD/VES 913.46 ▼ 0.22% USD/PAB 1.00 — 0.00% USD/BZD 2.00 — 0.00% USD/JMD 157.39 ▲ 2.57% USD/TTD 6.70 ▲ 1.98% EUR/BRL 6.38 ▲ 0.43% BRENT 89.21 ▼ 4.22% WTI 82.94 ▼ 3.57% IRON ORE 161.91 — — COPPER 5.66 ▼ 5.29% GOLD 3,758 ▼ 2.75% SILVER 44.96 ▼ 4.93% SOY 1,218 ▼ 0.61% CORN 441.25 ▼ 1.23% WHEAT 593.75 ▼ 0.25% COFFEE 273.55 ▼ 4.55% SUGAR 18.17 — 0.00% ORANGE JUICE 129.40 ▼ 4.15% COTTON 80.95 ▲ 4.69% COCOA 5,002 ▼ 0.56% BEEF 218.75 ▼ 0.01% CATTLE 336.30 ▲ 0.22% LITHIUM 55.54 ▼ 1.57% PETR4 42.97 ▼ 2.30% VALE3 59.00 ▼ 2.22% ITUB4 40.40 ▼ 1.20% BBDC4 14.26 ▼ 1.04% ABEV3 15.97 ▲ 0.25% BBAS3 14.27 ▼ 2.39% B3SA3 14.12 ▼ 3.62% WEGE3 51.28 ▲ 0.25% PRIO3 62.06 ▼ 2.97% SUZB3 55.18 ▼ 0.38% RENT3 29.78 ▲ 0.40% AZZA3 16.12 ▲ 3.07% CSAN3 3.22 ▼ 0.92% RAIZ4 18.49 ▼ 3.24% PCAR3 3.03 ▲ 4.84% GMAT3 4.15 ▼ 0.72% PSSA3 44.87 ▼ 2.29% CVCB3 0.78 — 0.00% POSI3 3.23 ▲ 3.19% SLCE3 17.89 ▼ 0.94% NATU3 4.89 ▲ 2.95% BRKM5 2.61 ▼ 5.09% RANI3 8.08 ▼ 1.70% CSNA3 3.78 ▲ 0.27%
since 2009
Wednesday, November 18, 2026

Covid-19 Brazil

Due to Pandemic, Sales of Antidepressants in Mexico Increase 30%

By · · 3 min read

RIO DE JANEIRO, BRAZIL – The stress that the coronavirus pandemic has caused in the population in Mexico has led to an increase of up to 30% in the sale of antidepressants compared to the start of the health emergency, Mexican pharmacists said on Wednesday, December 23rd.

“There has been a sustained increase of 30% in the sale of antidepressants since the beginning of the pandemic,” said Juvenal Becerra, president of the National Union of Pharmacy Entrepreneurs (Unefarm), who attributed this situation to “stress caused to the population”.

The stress that the coronavirus pandemic has caused in the population in Mexico has led to an increase of up to 30% in the sale of antidepressants compared to the start of the health emergency, Mexican pharmacists said this Wednesday, December 23rd.
The stress that the coronavirus pandemic has caused in the population in Mexico has led to an increase of up to 30% in the sale of antidepressants.
RT
Ask Rio Times
17 years of Latin America reporting, on demand.
Open the full Ask Rio Times →

The increase in the sale of drugs such as diazepam, clonazepam or methylphenidate, recommended for the treatment of insomnia, panic disorders and depression, also report an increase of 20% for the National Association of Pharmacies of Mexico (Unafarmex), confirmed its president, Antonio Pascual.

Both agree that the increase in the sale of this type of medicine responds to a logical consequence of the stress caused by the recommendation to stay at home and the economic crisis derived from COVID-19.

However, Becerra explained that “the supply of these drugs has not reached a shortage like the one seen in prescription drugs for the treatment of COVID-19 symptoms, such as ivermectin, cyprolysin, dexamethasone and paracetamol.”

The LatAm Brief

One email, every weekday morning. What moved in Latin American markets, politics and expat life.

Yesterday’s subject line: “US Embassy warns Americans of Colombia strike Thursday”

Regarding the supply of medicines, he assured that Unefarm has product stocks for a total of 30 days; however, “material in warehouses may be modified by the exponential and worrying increase in infections,” Becerra lamented.

In addition, he revealed that “antidepressants have played a relevant role since the beginning of the pandemic” and predicted that this role will continue even until the vaccine can reach the entire population.

Both directors confirmed that the contingency brought an “alteration” to the pharmaceutical sector, since both accept that they have been in very complicated situations.

Both Pascual and Becerra agree that the pandemic has greatly altered the sale of different drugs, both those used to counteract COVID-19, as well as those prescribed for the emotional ravages.

Alejandro Jiménez Genchi, a teacher in psychiatry and president of the Mexican Academy of Sleep Medicine, said a few weeks ago that at least 60% of Mexicans have had their sleep affected due to the stress, anxiety and depression that the pandemic has generated. by coronavirus.

“With insomnia, a person who does not sleep well is exposed to cardiovascular, metabolic and emotional risks,” he said.

Genchi explained that people who sleep less than 6 hours a day have up to 66% risk of developing arterial hypertension, conditions that health authorities have reported can increase the risk of presenting a serious picture of symptoms when infected by coronavirus.

COVID-19 has left more than 1.3 million infections in Mexico and exceeds 118,000 deaths since its arrival in Mexico in February of this year.

This article was produced by The Rio Times’ automated AI newsroom. Editorial responsibility: Matthias Camenzind, Publisher and Editor-in-Chief. The Rio Times also runs Ask Rio Times, which answers from 100,000+ of our own articles, the daily Latin America Power Map, and prediction-market odds on elections and markets.. How we use AI · Report an error

The Rio Times · Power Map
See who really holds power in Latin America
Click to open the Power Map →

Brazil runoff date: Sunday, October 25, poll closing times and when results start · Brazil runoff polls: Flávio 51%, Lula 49% · Kalshi and Polymarket odds

Rotate for Best Experience

This report is optimized for landscape viewing. Rotate your phone for the full experience.